Literature DB >> 15482546

Autoimmune cholangitis in a patient with thymoma.

Jang-Ha Kim1, Byung-Ho Kim, Youn-Wha Kim, Joo-Cheol Park, Yong Hee Jung, Byoung Ook Lee, Yo Seb Han, Seok Ho Dong, Hyo Jong Kim, Young-Woon Chang, Joung Il Lee, Rin Chang.   

Abstract

Autoimmune cholangitis is characterized biochemically by chronic cholestasis and histopathologically by chronic non-suppurative destructive cholangitis. It is associated with positive antinuclear antibody test and negative antimitochondrial antibody test results. Recently, we experienced a case of a 35-year-old woman with autoimmune cholangitis associated with thymoma who presented with pruritus, jaundice, chronic fatigue and anterior chest discomfort. Her laboratory examinations revealed marked increases in levels of serum alkaline phosphatase and gamma-glutamyl transpeptidase. In serological tests, antinuclear antibody was found, but antimitochondrial antibody was not. Liver biopsy findings were compatible with chronic non-suppurative destructive cholangitis. On computed tomography (CT) of the chest, a large anterior mediastinal mass was found. The mass was totally resected and the patient was treated with ursodeoxy cholic acid. Thereafter, her clinical symptoms improved and liver functions completely returned to the normal range. We describe here an uncommon association of autoimmune cholangitis with thymoma, which has not been reported previously in the English-written literature.

Entities:  

Mesh:

Year:  2004        PMID: 15482546     DOI: 10.1111/j.1440-1746.2002.03239.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  2 in total

1.  Postoperative radiation therapy for non-small cell lung cancer and thymic malignancies.

Authors:  Daniel R Gomez; Ritsuko Komaki
Journal:  Cancers (Basel)       Date:  2012-03-14       Impact factor: 6.639

2.  Effect of chemotherapy on autoimmune hepatitis in thymoma: a case report and literature review.

Authors:  Nesrine Mejri; Imen Chabchoub; Ines Gargouri; Imtinen Belaid; Faten Ezairi; Sihem Hmissa; Slim Ben Ahmed
Journal:  Cancer Biol Med       Date:  2013-09       Impact factor: 4.248

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.